- Home
- AARD vs REKR Comparison
AARD vs REKR Comparison
Compare AARD & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- REKR
- Stock Information
- Founded
- AARD 2017
- REKR 2017
- Country
- AARD United States
- REKR United States
- Employees
- AARD N/A
- REKR N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- REKR Telecommunications Equipment
- Sector
- AARD Health Care
- REKR Telecommunications
- Exchange
- AARD Nasdaq
- REKR Nasdaq
- Market Cap
- AARD 154.9M
- REKR 153.5M
- IPO Year
- AARD 2025
- REKR N/A
- Fundamental
- Price
- AARD $13.68
- REKR $1.34
- Analyst Decision
- AARD Strong Buy
- REKR
- Analyst Count
- AARD 5
- REKR 0
- Target Price
- AARD $33.00
- REKR N/A
- AVG Volume (30 Days)
- AARD 84.2K
- REKR 3.5M
- Earning Date
- AARD 08-14-2025
- REKR 08-13-2025
- Dividend Yield
- AARD N/A
- REKR N/A
- EPS Growth
- AARD N/A
- REKR N/A
- EPS
- AARD N/A
- REKR N/A
- Revenue
- AARD N/A
- REKR $45,448,000.00
- Revenue This Year
- AARD N/A
- REKR $8.68
- Revenue Next Year
- AARD N/A
- REKR $21.45
- P/E Ratio
- AARD N/A
- REKR N/A
- Revenue Growth
- AARD N/A
- REKR 17.97
- 52 Week Low
- AARD $4.88
- REKR $0.62
- 52 Week High
- AARD $19.58
- REKR $2.67
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- REKR 58.96
- Support Level
- AARD N/A
- REKR $1.19
- Resistance Level
- AARD N/A
- REKR $1.42
- Average True Range (ATR)
- AARD 0.00
- REKR 0.08
- MACD
- AARD 0.00
- REKR 0.01
- Stochastic Oscillator
- AARD 0.00
- REKR 73.44
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.